A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Clinical trial NCT02829099 · COMPLETED
Trial details
- NCT number
- NCT02829099
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-21
- Primary completion
- 2021-07-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.